Francesco Maria Marincola
Observed names: F M Marincola, F Marincola, F. M. Marincola, F. Marincola, F.M. Marincola, FRANCESCO M. MARINCOLA, Francesco M Marincola, Francesco M Marincola Open Access, Francesco M. Marincola, Francesco Marincola, Francesco M Marincola, Francesco M. Marincola, Francesco M. Marincola, Francesco M. Marincola, M Marincola, Francesco, M. Marincola, Francesco, Marincola Francesco M, Marincola, F.M., Marincola, Francesco, Marincola, Francesco M, Marincola, Francesco M.
Observed institutions: MedStar Washington Hospital Center, SRI International, National Institutes of Health, Advanced Cell Technology (United States), The University of Texas MD Anderson Cancer Center, Howard Hughes Medical Institute, University of Padua, University of Louisville, Johns Hopkins University, University of California, Los Angeles, University of Pittsburgh, The Lundquist Institute, Pfizer (United States), Virginia Commonwealth University, Australian Red Cross Lifeblood, University of Milan, Brown University, Istituto Superiore di Sanità, University of Virginia Health System, Society for Immunotherapy of Cancer, Soonchunhyang University Hospital Seoul, Washington Hospital, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Manchester, AbbVie (United States), Moffitt Cancer Center, Yale University, University of Chicago, Blood Systems Research Institute, University Hospital in Motol, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, National Cancer Institute, UPMC Hillman Cancer Center, Sidra Medical and Research Center, IRCCS Ospedale San Raffaele, National Cancer Institute, National Institute of Allergy and Infectious Diseases, University of Pittsburgh Medical Center, Stanford Medicine, Gilead Sciences (United States), National Cancer Institute, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Kite (United States), Refuge Biotechnologies (United States), Genelux (United States), Center for Cancer Research, Weill Cornell Medical College in Qatar, National Research Council, National Institutes of Health Clinical Center, Harbor–UCLA Medical Center, Instituto Nazionale Tumori Regina Elena, University of Virginia Cancer Center, UCLA Jonsson Comprehensive Cancer Center, VCU Massey Comprehensive Cancer Center, Division of Cancer Epidemiology and Genetics, HLA Laboratory, Kite Pharma (United States), AbbVie Biotherapeutics (United States), MedStar Health Research Institute, Fenway Health, Hamad Medical Corporation, New York University, Southern Medical University, Martin Luther University Halle-Wittenberg, Columbia University, Charité – Universitätsmedizin Berlin, University of Tübingen, University of Genoa, Vion Pharmaceuticals (United States), Qatar Foundation, Stanford University, Icahn School of Medicine at Mount Sinai
ORCID: 0000-0001-6423-391X
Observed ORCID: 0000-0001-6423-391X
OpenAlex ID: A5059941996